top of page

ADHD Clinical Research Trials

adhd paid clinical trials

Status: 

Enrolling

Age

13-65

Length of Trial

6-8 weeks

Visits

9-10 

Compensation

Yes

WHAT CAUSES ADHD?

ADHD is a severe mental disorder that affects those parts of the brain, which help to focus, plan, and execute tasks. 

 

ADHD is the acronym for Attention Deficit Hyperactivity Disorder, which, according to various clinical research studies, affects 5 percent of adults and 11 percent of children in the United States. 

adhd paid clinical trials

Contrary to the general belief, ADHD is neither a behavior disorder nor a mental illness. It is also not a specific learning disorder. Instead, People who have ADHD have impairment in the development of the brain and its executive functions and. 

 

SYMPTOMS OF ADHD

The common ADHD symptoms include hyperactivity and inattentiveness; however, the symptoms can also vary from person to person and its subtype. It gets even more challenging to diagnose ADHD symptoms in adults and girls. If you are experiencing any of the following symptoms, we suggest you consult a psychiatrist or enroll in a clinical research study:

  • Inattentiveness

  • Difficulty focusing

  • Weak impulse control

  • Poor time management

  • Extreme emotional conditions

  • Hyperactivity

  • Executive dysfunction

 

ELIGIBILITY CRITERIA FOR ADHD CLINICAL TRIALS

Eligible studies are those that use the diagnostic criteria from DSM-III, DSM-II:

INCLUSION CRITERIA:

  • positive attention-deficit/hyperactivity disorder (ADHD) diagnosis with at least moderate severity

  • male or female of age group between 18 to 30 years

  • can swallow capsules

  • must not have cognitive impairment

  • must be reliable to keep appointments for clinic visits and all related tests

 

EXCLUSION CRITERIA:

  • patients diagnosed with obsessive-compulsive disorder, bipolar affective disorder, or psychosis

  • women who are pregnant or breastfeeding

  • patients with dementia or traumatic brain injury

  • patients with a history of a severe allergy to atomoxetine

  • have untreated hypertension or a thyroid problem

  • have severe illness including any heart, liver, kidney, respiratory, blood, endocrine, or neuromuscular diseases

 

BENEFITS OF TAKING PART IN THE ADHD CLINICAL RESEARCH TRIAL

Participating in a clinical trial may not sound as appealing but has several substantial benefits:

 

  • The doctors running the clinical trials help the enrolling participants to understand their illness fully. To effectively treat ADHD, it is essential to understand it, including the symptoms and types entirely. 

  • Some ADHD trials are observational, while others include trying medicines that are not yet available to the general public. These medications are, however, declared safe to use after specific tests. The clinical trials usually test the effectiveness of the medicines.

  • The participants are compensated for enrolling in clinical research trials, California, for ADHD.

  • The participants enrolling in clinical research studies get free medicines and any health checks.

  • The participants enrolling in ADHD clinical trials can benefit other prospect patients by participating in the assessment of the safety and efficiency of new medicines.

  • The frequent medical checkups conducted at a clinical trial can help people with severe ADHD to closely monitor ADHD treatment.

bottom of page